A controversial ALS drug potentially worth $1 billion is on the cusp of FDA approval. It could change Amylyx’s fortunes and be a much-needed treatment for the rare disease.

“I think it’s been interesting that there have been concerns or controversy when we think that this really isn’t controversial,” co-CEO said.

Read the full article here

Source: Business Insider
Categories: Latest Headlines, Rare Disease
Tweets with this article
ALS Advocacy
A controversial ALS drug potentially worth $1 billion is on the cusp of FDA approval. It could change Amylyx's fortunes and be a much-needed treatment for the rare disease. https://t.co/ve8XQK3ogV via @businessinsider

Related Articles